Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study will evaluate the safety and tolerability of oxymetazoline HCl cream 1.0% when used as an adjunctive treatment to energy-based therapy for participants with moderate to severe persistent facial erythema associated with rosacea.
Epistemonikos ID: b80a1795a60c343cca48a24c064a6f5908d7fbad
First added on: May 21, 2024